Literature DB >> 12594725

Comparison of MR and PET imaging for the evaluation of liver metastases.

Ming Yang1, Diego R Martin, Nevzat Karabulut, Mathis P Frick.   

Abstract

PURPOSE: To compare the accuracy of fluoro-18-deoxyglucose positron emission tomography (FDG-PET) and dynamic-enhanced magnetic resonance imaging (MRI) scans in the diagnosis of liver metastatic lesions from colon and other sources.
MATERIALS AND METHODS: Thirty consecutive patients with known or suspected metastatic lesions were scanned by both MRI and PET. Histopathology and/or clinical outcome, including cross-sectional imaging follow up, were used as a gold standard.
RESULTS: Of 30 patients, 16 were positive by pathology and/or clinical outcome and 14 were negative for liver metastases. The sensitivity, specificity, and positive and negative predictive values on MRI were 85.7%, 100%, 100%, and 89%, respectively, compared to 71%, 93.7%, 90.9%, and 79% on FDG-PET. The difference between the two methods was not significant (X(2) = 0.2, P > 0.05).
CONCLUSION: Our study showed no significant difference in detection of liver metastases using MRI or FDG-PET. However, MRI has advantages in spatial resolution and lesion characterization. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12594725     DOI: 10.1002/jmri.10265

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  8 in total

1.  Sensitivity of magnetic resonance imaging in the detection of colorectal liver metastases.

Authors:  S Blyth; A Blakeborough; M Peterson; I C Cameron; A W Majeed
Journal:  Ann R Coll Surg Engl       Date:  2008-01       Impact factor: 1.891

Review 2.  123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.

Authors:  Gitta Bleeker; Godelieve A M Tytgat; Judit A Adam; Huib N Caron; Leontien C M Kremer; Lotty Hooft; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2015-09-29

3.  Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination.

Authors:  D M Koh; G Brown; A M Riddell; E Scurr; D J Collins; S D Allen; I Chau; D Cunningham; N M deSouza; M O Leach; J E Husband
Journal:  Eur Radiol       Date:  2008-01-12       Impact factor: 5.315

4.  Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.

Authors:  Jacqueline Dinnes; Lavinia Ferrante di Ruffano; Yemisi Takwoingi; Seau Tak Cheung; Paul Nathan; Rubeta N Matin; Naomi Chuchu; Sue Ann Chan; Alana Durack; Susan E Bayliss; Abha Gulati; Lopa Patel; Clare Davenport; Kathie Godfrey; Manil Subesinghe; Zoe Traill; Jonathan J Deeks; Hywel C Williams
Journal:  Cochrane Database Syst Rev       Date:  2019-07-01

5.  Comparison of MRI and 18F-FDG PET/CT in the Liver Metastases of Gastrointestinal and Pancreaticobiliary Tumors.

Authors:  Mehmet Tahtabasi; Sukru Mehmet Erturk; Muzaffer Basak
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2021-03-17

Review 6.  Clinical application of 18F-fluorodeoxyglucose positron emission tomography for assessment and evaluation after therapy for malignant hepatic tumor.

Authors:  Masakatsu Tsurusaki; Masahiko Okada; Hiroyuki Kuroda; Mitsuru Matsuki; Kazunari Ishii; Takamichi Murakami
Journal:  J Gastroenterol       Date:  2013-03-26       Impact factor: 7.527

7.  Defining the Modalities of Intravenous Contrast Application During the Diagnostics of Hepatic Metastases with Computerized Tomography.

Authors:  Arben Kutllovci; Halit Ymeri; Drita Zogaj; Skender Kutllovci; Dukagjin Zogaj
Journal:  Acta Inform Med       Date:  2016-02-02

Review 8.  Surgical treatment of liver tumors - own experience and literature review.

Authors:  Aliaksandr Tarasik; Jerzy Jaroszewicz; Marcin Januszkiewicz
Journal:  Clin Exp Hepatol       Date:  2017-01-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.